{"symbol":"BSX","fiscalQuarter":"Q4-2011","reportDate":"2012-02-02","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2011","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 4.11%","keyNumbers":[{"metric":"EPS","actual":"$0.13","expected":"N/A","surprise":"+60.49%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product areas.","They noted ongoing challenges in the market but expressed confidence in future growth."],"summary":"Overall, management remains cautiously optimistic about the company's direction. They acknowledged market challenges but emphasized their commitment to innovation."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a significant beat on EPS, which reflects better-than-expected profitability. However, the stock fell by 4.11% in reaction, likely due to the lack of revenue details and no guidance for the future. Investors may be concerned about the company's ability to navigate market challenges despite the positive EPS surprise.","metaDescription":"Boston Scientific (BSX) Q4 2011 earnings: EPS beat by 60.49%. Stock down 4.11%. Full breakdown."}}